aspirin has been researched along with 4-hydroxybenzoic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Grischkowsky, D; Harsha, SS; Laman, N | 1 |
| Al-Haza'a, A; Bowen, ID; Brennan, P; Buggins, AG; Fegan, C; Hewamana, S; Lin, TT; Mahdi, AJ; Mahdi, E; Mahdi, JG; Morgan, L; Pearce, L; Pepper, C; Walsby, E | 1 |
1 review(s) available for aspirin and 4-hydroxybenzoic acid
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
2 other study(ies) available for aspirin and 4-hydroxybenzoic acid
| Article | Year |
|---|---|
Narrow-line waveguide terahertz time-domain spectroscopy of aspirin and aspirin precursors.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Benzoic Acid; Hydroxybenzoates; Microwaves; Parabens; Radio Waves; Salicylic Acid; Spectrum Analysis | 2008 |
Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX-2.
Topics: ADP-ribosyl Cyclase 1; Aged; Animals; Antineoplastic Agents; Apoptosis; Aspirin; Caspase 3; Caspase Inhibitors; CD40 Antigens; Coculture Techniques; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Membrane Glycoproteins; Mice; Oligopeptides; Parabens; Salicylic Acid; Transcription Factor RelA; Transcription, Genetic; Tumor Cells, Cultured; ZAP-70 Protein-Tyrosine Kinase | 2011 |